Skip to main content

Mammoth Biosciences

Mammoth Biosciences is developing the world's first CRISPR-based disease detection platform capable of sensing any strand of DNA and RNA with molecular-level accuracy. Similar to the way Google searches and finds information online, Mammoth searches and finds nucleic acids indicative of disease and, with it, aims to democratize disease detection in health care as well as across industries such as agriculture, manufacturing, forensics and more.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.